HPC Biosciences [HPBL] vs EPL [EPL] Detailed Stock Comparison

HPC Biosciences Ltd.

BSE
Loading...

EPL Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: HPC Biosciences Ltd. wins in 12 metrics, EPL Ltd. wins in 7 metrics, with 0 ties. HPC Biosciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric HPC Biosciences Ltd. EPL Ltd. Better
P/E Ratio (TTM) 9.38 18.24 HPC Biosciences Ltd.
Price-to-Book Ratio 2.55 2.78 HPC Biosciences Ltd.
Debt-to-Equity Ratio 219.28 32.30 EPL Ltd.
PEG Ratio 0.03 -1.41 HPC Biosciences Ltd.
EV/EBITDA 8.34 8.83 HPC Biosciences Ltd.
Profit Margin (TTM) 3.53% 8.76% EPL Ltd.
Operating Margin (TTM) 14.19% 12.93% HPC Biosciences Ltd.
EBITDA Margin (TTM) 14.19% 12.93% HPC Biosciences Ltd.
Return on Equity 12.16% 15.22% EPL Ltd.
Return on Assets (TTM) 3.38% 8.96% EPL Ltd.
Free Cash Flow (TTM) $-189.52M $4.32B EPL Ltd.
Dividend Yield N/A 2.31% N/A
1-Year Return 42.25% -13.50% HPC Biosciences Ltd.
Price-to-Sales Ratio (TTM) 0.38 1.60 HPC Biosciences Ltd.
Enterprise Value $4.40B $79.42B EPL Ltd.
EV/Revenue Ratio 0.78 1.74 HPC Biosciences Ltd.
Gross Profit Margin (TTM) 48.80% 60.61% EPL Ltd.
Revenue per Share (TTM) $434 $143 HPC Biosciences Ltd.
Earnings per Share (Diluted) $21.73 $12.51 HPC Biosciences Ltd.
Beta (Stock Volatility) -0.01 0.38 HPC Biosciences Ltd.

HPC Biosciences Ltd. vs EPL Ltd. Stock Performance Analysis

Loading Price Chart...

HPBL
EPL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
HPC Biosciences Ltd.-0.80%-8.93%-12.73%34.39%24.06%36.37%
EPL Ltd.0.25%-2.07%-6.24%2.96%4.41%-2.43%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
HPC Biosciences Ltd.42.25%-0.26%-59.52%-59.52%-59.52%-59.52%
EPL Ltd.-13.50%6.67%-13.34%129.36%824.89%492.16%

Performance & Financial Health Analysis: HPC Biosciences Ltd. vs EPL Ltd.

MetricHPBLEPL
Market Information
Market Cap i₹2.17B₹71.48B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i9,1161,314,989
90 Day Avg. Volume i5,7081,213,817
Last Close₹248.00₹210.94
52 Week Range₹140.10 - ₹284.45₹176.40 - ₹254.00
% from 52W High-12.81%-16.95%
All-Time High₹704.50 (Jan 17, 2022)₹318.60 (Aug 17, 2020)
% from All-Time High-64.80%-33.79%
Growth Metrics
Quarterly Revenue Growth0.02%0.13%
Quarterly Earnings Growth3.27%-0.13%
Financial Health
Profit Margin (TTM) i0.04%0.09%
Operating Margin (TTM) i0.14%0.13%
Return on Equity (TTM) i0.12%0.15%
Debt to Equity (MRQ) i219.2832.30
Cash & Liquidity
Book Value per Share (MRQ)₹79.86₹82.01
Cash per Share (MRQ)₹1.91₹7.10
Operating Cash Flow (TTM) i₹-217,642,000₹4.33B
Levered Free Cash Flow (TTM) i₹96.26M₹3.59B
Dividends
Last 12-Month Dividend Yield iN/A2.31%
Last 12-Month Dividend iN/A₹5.00

Valuation & Enterprise Metrics Analysis: HPC Biosciences Ltd. vs EPL Ltd.

MetricHPBL (Apr 24, 2026)EPL (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i9.3818.24
Forward P/E iN/A14.95
PEG Ratio i0.03-1.41
Price to Sales (TTM) i0.381.60
Price to Book (MRQ) i2.552.78
Market Capitalization
Market Capitalization i₹2.17B₹71.48B
Enterprise Value i₹4.40B₹79.42B
Enterprise Value Metrics
Enterprise to Revenue i0.781.74
Enterprise to EBITDA i8.348.83
Risk & Other Metrics
Beta i-0.010.38
Book Value per Share (MRQ) i₹79.86₹82.01

Financial Statements Comparison: HPC Biosciences Ltd. vs EPL Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHPBL (2025)EPL (2025)
Revenue/Sales i4.61B41.61B
Cost of Goods Sold i3.93B21.03B
COGS % of Revenue i85.2%50.5%
Gross Profit i680.37M20.59B
Gross Margin i14.8%49.5%
Research & Development iN/AN/A
Operating Income (EBIT) i300.06M5.27B
Operating Margin i6.5%12.7%
EBITDA i386.57M8.77B
EBITDA Margin i8.4%21.1%
Pre-Tax Income i195.76M4.22B
Pre-Tax Income % of Revenue i4.2%10.1%
Income Tax i46.49M577.00M
Income Tax % of Revenue i1.0%1.4%
Net Income (Profit) i133.31M3.64B
Profit Margin i2.9%8.7%

Balance Sheet & Liquidity Metrics

MetricHPBL (2025)EPL (2025)
Cash & Equivalents i7.79M1.91B
Total Current Assets i1.80B17.34B
Total Current Assets % of Revenue i39.0%41.7%
Total Current Liabilities i1.70B11.52B
Total Current Liabilities % of Revenue i36.9%27.7%
Long-Term Debt i324.35M4.03B
Long-Term Debt % of Revenue i7.0%9.7%
Total Shareholders Equity i791.64M23.59B
Retained Earnings i-337.75M12.21B
Retained Earnings % of Revenue i-7.3%29.3%
Property, Plant & Equipment i80.41M2.43B

Cash Flow Statement Comparison

MetricHPBL (2025)EPL (2025)
Operating Cash Flow i-217.64M4.33B
Operating Cash Flow % of Revenue i-4.7%10.4%
Capital Expenditures i2.99M-3.56B
Free Cash Flow i-189.52M4.32B
FCF Margin i-4.1%10.4%
Debt Repayment i-151.53M-10.83B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricHPBLEPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.67M320.25M
Float Shares i1.06M139.15M
% Held by Insiders i92.61%56.30%
% Held by Institutions i0.00%18.46%
% Held by Public i7.39%25.24%

Dividend Analysis & Yield Comparison: HPC Biosciences Ltd. vs EPL Ltd.

MetricHPBLEPL
Last 12-Month Dividend iN/A₹5.00
Last 12-Month Dividend Yield iN/A2.31%
3-Year Avg Annual Dividend iN/A₹4.70
3-Year Avg Dividend Yield iN/A1.07%
3-Year Total Dividends iN/A₹14.10
Ex-Dividend DateN/ANov 17, 2025